Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

New software application for personalized medicine presented

April 30, 2013

No Comments

Impel NeuroPharma completes proof-of-concept study for nose-to-brain drug delivery technology

April 24, 2013

No Comments

Sareum and SRI International sign codevelopment agreement for TYK2 inhibitors

April 23, 2013

No Comments

Interprotein and Takeda sign new molecular design agreement

April 19, 2013

No Comments

Zymeworks achieves second milestone in collaboration with Merck & Co.

April 17, 2013

No Comments

Santaris and Bristol-Myers Squibb establish strategic alliance

April 16, 2013

No Comments

GSK and A*STAR's ICES to develop evidence-based formulations

April 10, 2013

No Comments

Crown Bioscience and Horizon Discovery sign new collaboration agreement

April 9, 2013

No Comments

BIND Therapeutics and Pfizer to develop multiple Accurins

April 5, 2013

No Comments

Ra Pharmaceuticals collaborates with Merck & Co. on Cyclomimetics

April 5, 2013

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies
RSS

New software application for personalized medicine presented

Impel NeuroPharma completes proof-of-concept study for nose-to-brain drug delivery technology

Sareum and SRI International sign codevelopment agreement for TYK2 inhibitors

Interprotein and Takeda sign new molecular design agreement

Zymeworks achieves second milestone in collaboration with Merck & Co.

Santaris and Bristol-Myers Squibb establish strategic alliance

GSK and A*STAR's ICES to develop evidence-based formulations

Crown Bioscience and Horizon Discovery sign new collaboration agreement

BIND Therapeutics and Pfizer to develop multiple Accurins

Ra Pharmaceuticals collaborates with Merck & Co. on Cyclomimetics

Today's news in brief

Today's news in brief

Second insulin receptor offers new therapeutic avenues

Mechanism underlying so-called idiopathic autism inception unveiled

Drug duo to Repare lack in gyno cancers? Phase I shows promise

Drug design, drug delivery and technologies RSS

Drug design, drug delivery and technologies
RSS